Is schizophrenia still one entity with similar symptomatic patterns, neurobiological characteristics, and treatment perspectives? Hans-Jürgen Möller Editorial 28 July 2018 Pages: 525 - 527
The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F]fallypride Yo-Han JooJeong-Hee KimJong-Hoon Kim Original Paper 16 June 2017 Pages: 529 - 540
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort G. FondN. Resseguierthe FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group Original Paper 10 November 2017 Pages: 541 - 553
Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats Martina von WilmsdorffFabian MantheyPeter J. Gebicke-Haerter Original Paper 05 February 2018 Pages: 555 - 563
Elemental fingerprinting of schizophrenia patient blood plasma before and after treatment with antipsychotics Alessandra SussuliniHelena Munhoz ErbolatoDaniel Martins-de-Souza Original Paper 29 August 2017 Pages: 565 - 570
COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients Anna V. KirenskayaZinaida I. StorozhevaRobert D. E. Sewell Original Paper Open access 10 February 2018 Pages: 571 - 584
Identification of putative second genetic hits in schizophrenia carriers of high-risk copy number variants and resequencing in additional samples Julio Rodríguez-LópezBeatriz SobrinoJavier Costas Original Paper 18 April 2017 Pages: 585 - 592
Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial) Stefanie J. SchmidtMatthias LangeMartin Lambert Original Paper 24 May 2017 Pages: 593 - 602
Correspondence between negative symptoms and potential sources of secondary negative symptoms over time Aida FarrenyMark SavillStefan Priebe Original Paper 02 June 2017 Pages: 603 - 609
Effectiveness and cost-effectiveness of an integrated care program for schizophrenia: an analysis of routine data Linda KerkemeyerJürgen WasemJanine Biermann Original Paper 08 August 2017 Pages: 611 - 619
